I have lost none of my belief regarding the long term expectations for CTIX.  I just don't think we start seeing it until late next year.  In 2-3 years I think we could attain levels that will stun people.

Kevetrin looks as potent as ever, Brilacidin will surprise to the upside tremendously IMO, and I believe Prurisol should be a big winner even if it is black boxed resulting in a loss of less than 10% of potential sales.  I believe Dr M thinks it will do the job with negligible side effects to greatly outdo any competition on the market.  That's 3 for 3 and the numbers should be rising faster than my recent golf scores and that's pretty quick.

I have been slapped in the face with reality from you, seel, and others who actually know the ropes regarding biotechs over the last year but my eternal optimism continues to plow ahead.